Portal de investigación
A RANDOMIZED, DOUBLÉ-BLIND, PLACEBO-CONTROLLE ADJUVANT TRIAL IN NEWLY DIAGNOSED PRIMARY GLIOBLASTOMA SUBJECTS TO ASSESS THE EFFICACY AND SAFETY OF 2-HYDROXYLEIC ACID (2-OHOA) IN COMBINATION WITH RADIOTHERAPY AND TEMOZOLMIDE STANDARD OF CARE TREATMENT.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
LIOPHARMA THERAPEUTICS S.L.
Cita
A RANDOMIZED, DOUBLÉ-BLIND, PLACEBO-CONTROLLE ADJUVANT TRIAL IN NEWLY DIAGNOSED PRIMARY GLIOBLASTOMA SUBJECTS TO ASSESS THE EFFICACY AND SAFETY OF 2-HYDROXYLEIC ACID (2-OHOA) IN COMBINATION WITH RADIOTHERAPY AND TEMOZOLMIDE STANDARD OF CARE TREATMENT. (MIN-003-1806). LIOPHARMA THERAPEUTICS S.L. 2019-2023. IP:REGINA GIRONÉS SARRIÓ.